22138757

9780309212809

Risk-Characterization Framework for Decision-Making at the Food and Drug Administration

$74.22
$3.95 Shipping
  • Condition: New
  • Provider: Bookjunction Contact
  • Provider Rating:
    73%
  • Ships From: STERLING HEIGHTS, MI
  • Shipping: Standard
  • Comments: New, US edition. Satisfaction guaranteed!!

seal  
$78.32
$3.95 Shipping
  • Condition: Good
  • Provider: Bonita Contact
  • Provider Rating:
    0%
  • Ships From: Multiple Locations
  • Shipping: Standard
  • Comments: Access codes and supplements are not guaranteed with used items. May be an ex-library book.

seal  

Ask the provider about this item.

Most renters respond to questions in 48 hours or less.
The response will be emailed to you.
Cancel
  • ISBN-13: 9780309212809
  • ISBN: 0309212804
  • Publication Date: 2011
  • Publisher: National Academies Press

AUTHOR

Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, National Research Council

SUMMARY

Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II is the author of 'Risk-Characterization Framework for Decision-Making at the Food and Drug Administration', published 2011 under ISBN 9780309212809 and ISBN 0309212804.

[read more]

Questions about purchases?

You can find lots of answers to common customer questions in our FAQs

View a detailed breakdown of our shipping prices

Learn about our return policy

Still need help? Feel free to contact us

View college textbooks by subject
and top textbooks for college

The ValoreBooks Guarantee

The ValoreBooks Guarantee

With our dedicated customer support team, you can rest easy knowing that we're doing everything we can to save you time, money, and stress.